Moreover, rapamycin, a well-established inhibitor of mTOR/p70S6K, inhibits resistin-induced ovarian cancer cell proliferation by blocking 70 kDa S6 kinase, which is a key element of mTOR signaling [71]. The gene discussed is RPS6KB1; the disease is ovarian carcinoma.